Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Neoplasm | 1 | 2019 | 54 | 0.650 |
Why?
|
| Histocompatibility Antigens | 1 | 2018 | 8 | 0.600 |
Why?
|
| Epitope Mapping | 1 | 2018 | 38 | 0.600 |
Why?
|
| Epitopes | 1 | 2018 | 181 | 0.550 |
Why?
|
| Software | 1 | 2018 | 121 | 0.550 |
Why?
|
| Computational Biology | 1 | 2018 | 150 | 0.540 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 448 | 0.530 |
Why?
|
| Peptides | 1 | 2018 | 283 | 0.500 |
Why?
|
| Neoplasms | 2 | 2022 | 768 | 0.430 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2022 | 44 | 0.370 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2022 | 48 | 0.360 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2022 | 89 | 0.350 |
Why?
|
| Mice | 6 | 2022 | 4478 | 0.240 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1406 | 0.220 |
Why?
|
| Fetal Diseases | 1 | 2022 | 18 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 94 | 0.190 |
Why?
|
| Interferons | 1 | 2022 | 68 | 0.190 |
Why?
|
| Antigen Presentation | 1 | 2022 | 78 | 0.190 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 150 | 0.190 |
Why?
|
| Animals | 6 | 2022 | 10093 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2022 | 141 | 0.170 |
Why?
|
| Mice, Inbred Strains | 1 | 2019 | 61 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 278 | 0.170 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2019 | 45 | 0.160 |
Why?
|
| H-2 Antigens | 1 | 2018 | 14 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 21 | 0.150 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 75 | 0.150 |
Why?
|
| Ligands | 1 | 2018 | 170 | 0.140 |
Why?
|
| Haplotypes | 1 | 2018 | 279 | 0.140 |
Why?
|
| Female | 5 | 2022 | 14661 | 0.140 |
Why?
|
| Binding Sites | 1 | 2018 | 342 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 188 | 0.140 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 679 | 0.130 |
Why?
|
| Protein Binding | 1 | 2018 | 637 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 446 | 0.130 |
Why?
|
| Cystamine | 1 | 2015 | 1 | 0.120 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1271 | 0.110 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 7 | 0.110 |
Why?
|
| Humans | 6 | 2022 | 27165 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 50 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2015 | 293 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2014 | 149 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 146 | 0.100 |
Why?
|
| Infant, Premature | 2 | 2022 | 133 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2022 | 846 | 0.080 |
Why?
|
| Biomarkers | 2 | 2022 | 738 | 0.080 |
Why?
|
| Acetylglucosamine | 1 | 2022 | 15 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 45 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 63 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 11 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 57 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 81 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 158 | 0.040 |
Why?
|
| Transcriptome | 1 | 2022 | 205 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 967 | 0.040 |
Why?
|
| Factor XIa | 1 | 2015 | 2 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2015 | 8 | 0.030 |
Why?
|
| Fibrin | 1 | 2015 | 17 | 0.030 |
Why?
|
| Thrombin | 1 | 2015 | 68 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 6 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2015 | 116 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 34 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2014 | 76 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 133 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 140 | 0.030 |
Why?
|
| Rats | 1 | 2015 | 1554 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 763 | 0.020 |
Why?
|